TRANSLATE BIO
Translate Bio, Inc.
Application Filed: 2021-03-25
Trademark Application Details
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 90602577 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Christina M. Licursi |
| Attorney Docket Number | R06932000101 |
Timeline
| 2021-03-25 | Application Filed |
| 2021-03-29 | Location: NEW APPLICATION PROCESSING |
| 2021-03-29 | Status: Live/Pending |
| 2021-03-30 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Translate Bio, Inc. |
| Address | 29 Hartwell Avenue Lexington DE 02421 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; medicines for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; biological preparations for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; biotherapeutics, namely, biological preparations for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; biosimilars, namely, biological preparations for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; therapeutic and prophylactic vaccines |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2021-03-29 | 1 NWAP I:Incoming Correspondence |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2021-05-10 | 2 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-05-10 | 3 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-05-10 | 4 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-05-10 | 5 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2021-05-10 | 6 CHAN I:Incoming Correspondence |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2021-06-11 | 7 COAR I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-06-11 | 8 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2021-06-11 | 9 CHAN I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-06-30 | 10 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2021-11-02 | 11 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2021-11-16 | 12 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2021-11-16 | 13 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2021-11-16 | 14 GNRN O:Outgoing Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-01-05 | 15 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-01-05 | 16 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-01-05 | 17 TCCA I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2022-05-12 | 18 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2022-05-12 | 19 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2022-05-12 | 20 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2022-05-12 | 21 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2022-05-12 | 22 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2022-05-25 | 23 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2022-06-14 | 24 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2022-06-14 | 25 NPUB E:E-Mail |
| EXTENSION OF TIME TO OPPOSE RECEIVED | 2022-07-08 | 26 ETOF T:TTAB Proceeding |
| EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | 2022-08-24 | 27 ETOP T:TTAB Proceeding |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2022-10-04 | 28 NOAM E:E-Mail |
| ASSIGNED TO EXAMINER | 2022-10-17 | 29 DOCK D:Assigned to Examiner |
| TEAS EXTENSION RECEIVED | 2023-03-31 | 30 EEXT I:Incoming Correspondence |
| SOU EXTENSION 1 FILED | 2023-03-31 | 31 EXT1 S: |
| SOU EXTENSION 1 GRANTED | 2023-03-31 | 32 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-04-04 | 33 EXRA E:E-Mail |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2023-09-26 | 34 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2023-09-26 | 35 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2023-09-26 | 36 TCCA I:Incoming Correspondence |
| TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | 2023-09-26 | 37 EWAF I:Incoming Correspondence |
| SOU TEAS EXTENSION RECEIVED | 2023-10-02 | 38 EEXT I:Incoming Correspondence |
| SOU EXTENSION 2 FILED | 2023-10-02 | 39 EXT2 S: |
| SOU EXTENSION 2 GRANTED | 2023-10-02 | 40 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-10-04 | 41 EXRA E:E-Mail |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2023-11-17 | 42 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2023-11-17 | 43 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2023-11-17 | 44 TCCA I:Incoming Correspondence |
| SOU TEAS EXTENSION RECEIVED | 2024-03-01 | 45 EEXT I:Incoming Correspondence |
| SOU EXTENSION 3 FILED | 2024-03-01 | 46 EXT3 S: |
| SOU EXTENSION 3 GRANTED | 2024-03-01 | 47 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2024-03-02 | 48 EXRA E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 TRANSLATE BIO 90602710 not registered Live/Pending |
Translate Bio, Inc. 2021-03-25 |
 TRANSLATE BIO 90602577 not registered Live/Pending |
Translate Bio, Inc. 2021-03-25 |
 TRANSLATE BIO 87396371 not registered Live/Pending |
TRANSLATE BIO, INC. 2017-04-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 